Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BREAST IMPLANT GLOBAL SETTLEMENT WILL BE RULED ON BY SEPT. 1

This article was originally published in The Gray Sheet

Executive Summary

BREAST IMPLANT GLOBAL SETTLEMENT WILL BE RULED ON BY SEPT. 1 after U.S District Court of Northern Alabama Judge Samuel Pointer considers whether the settlement is fair to women from other countries. After a three-day hearing, held beginning Aug. 18 in Birmingham, Pointer said Aug. 23 that he will issue a ruling by Sept. 1 on whether the silicone implant settlement is "fair, reasonable, adequate, and in the best interests of class members." Final approval of the class action case appears likely, but Pointer said that while he considers the $4.25 bil. settlement to be in the best interest of the American litigants, the question of fairness to foreign claimants caused him to delay his ruling.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002725

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel